Alaunos Therapeutics Inc (TCRT)
1.30
-0.06
(-4.41%)
USD |
NASDAQ |
May 03, 16:00
1.31
+0.01
(+0.77%)
After-Hours: 20:00
Alaunos Therapeutics Price to Book Value: 3.300 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 03, 2024 | 3.300 |
May 02, 2024 | 3.453 |
May 01, 2024 | 3.275 |
April 30, 2024 | 3.199 |
April 29, 2024 | 3.377 |
April 26, 2024 | 3.351 |
April 25, 2024 | 2.945 |
April 24, 2024 | 2.996 |
April 23, 2024 | 3.047 |
April 22, 2024 | 2.767 |
April 19, 2024 | 2.844 |
April 18, 2024 | 3.123 |
April 17, 2024 | 3.148 |
April 16, 2024 | 3.275 |
April 15, 2024 | 3.554 |
April 12, 2024 | 4.088 |
April 11, 2024 | 4.240 |
April 10, 2024 | 4.341 |
April 09, 2024 | 4.392 |
April 08, 2024 | 4.214 |
April 05, 2024 | 4.341 |
April 04, 2024 | 4.519 |
April 03, 2024 | 4.621 |
April 02, 2024 | 4.468 |
April 01, 2024 | 4.443 |
Date | Value |
---|---|
March 28, 2024 | 4.595 |
March 27, 2024 | 4.722 |
March 26, 2024 | 4.807 |
March 25, 2024 | 4.858 |
March 22, 2024 | 4.731 |
March 21, 2024 | 4.884 |
March 20, 2024 | 4.553 |
March 19, 2024 | 4.578 |
March 18, 2024 | 4.451 |
March 15, 2024 | 4.349 |
March 14, 2024 | 4.171 |
March 13, 2024 | 4.146 |
March 12, 2024 | 4.197 |
March 11, 2024 | 4.502 |
March 08, 2024 | 4.833 |
March 07, 2024 | 4.807 |
March 06, 2024 | 4.782 |
March 05, 2024 | 5.265 |
March 04, 2024 | 5.596 |
March 01, 2024 | 5.685 |
February 29, 2024 | 5.316 |
February 28, 2024 | 5.977 |
February 27, 2024 | 5.494 |
February 26, 2024 | 5.685 |
February 23, 2024 | 4.909 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.7738
Minimum
Dec 12 2023
19.88
Maximum
Jul 31 2019
5.670
Average
4.688
Median
Aug 10 2021
Price to Book Value Benchmarks
NovaBay Pharmaceuticals Inc | 2.094 |
Palatin Technologies Inc | -- |
iBio Inc | 0.7539 |
Theriva Biologics Inc | 0.187 |
Oragenics Inc | 3.043 |
Price to Book Value Related Metrics
Price | 1.30 |
Earnings Yield | -176.1% |
Market Cap | 20.82M |